Olfactory Network Testing with Electro-acupuncture for Subjective Cognitive Decline
Official title: Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline: A Multicenter Randomized Controlled Trial and fMRI Study
Run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT06758154 · Data updated 2026-11-12
This study tests whether electro-acupuncture can help people aged 55–79 with subjective cognitive decline, by looking at changes in their brain’s smell-related networks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years to 79 Years |
| Sex | All |
| Enrollment | 92 (estimated) |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | December 28, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT06758154 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 55–79 with diagnosed subjective cognitive decline, right-handed, with at least 8 years of education, and able to undergo MRI.
✕Probably not a fit
Individuals with conflicting medical conditions, MRI contraindications, or those already receiving other interventions that could confound results may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will use a multi-center ambispective design to combine fMRI and EEG during an olfactory task with an Oddball paradigm, aiming to map spatiotemporal patterns of entorhinal circuit damage in SCD and develop a middle fusion model of vulnerable brain networks. The study compares active electro-acupuncture to sham acupuncture to see if targeted neural changes correlate with clinical markers. Eligibility focuses on adults 55–79 with SCD, right-handed, and with sufficient education, who can consent and tolerate MRI. The trial seeks to identify biomarkers that predict progression to Alzheimer’s disease and to explore individualized intervention targets. No results are reported yet, and the approach blends neuroimaging with traditional acupuncture therapy.
Why it matters
Potential benefit: If successful, participants could gain access to a therapy that modulates brain networks associated with early cognitive decline and helps identify those at higher risk of progression.
How similar studies have gone: Prior work suggests olfactory and entorhinal network alterations are linked to cognitive decline, but this exact combined fMRI-EEG olfactory task with electro-acupuncture is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Meet the diagnostic criteria for SCD diseases; 2. 55-79 years old; 3. ≥8 years of schooling; 4. Right-handed; 5. Sign the informed consent. Exclusion Criteria: 1. Have received other antidepressant therapy or involved in other clinical trials in the previous 2weeks. 2. Infarct located in the left DLPFC. 3. Positive psychiatric history and major trauma exposure history, such as depression, epilepsy, etc., in the past. 4. Other serious concomitant diseases (aphasia, severe edema, venous thrombosis, arteriosclerosis occlusion, diabetic vascular disease, peripheral neuropathy, spinal lesions, brain trauma, intracranial infection, brain tumors, etc.) or secondary diseases (heart, liver, renal failure, etc.). 5. Infection around acupoints and/or intolerance to acupuncture manipulation. 6. MRI or rTMS contraindications (claustrophobia, metal implants, cochlear implants, impulsator, etc.).
Where it's running
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Bing Zhang
- Email: zhangbing_nanjing@nju.edu.cn
- Phone: 15851803070
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Daily-life Virtual Reality Training to Support Thinking and Daily Tasks in adults 50 and older
A touchscreen-based daily-life VR program is being tested to see if it helps people 50+ improve daily activities and thinking skills, especially for those at risk of dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease
This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne
-
Digital tools to predict Alzheimer's biology from risk factors
This study tests a digital, AI-based tool that analyzes modifiable and non-modifiable risk factors to see if it can predict biological changes linked to Alzheimer's disease in adults with MCI or SCD.
-
Personalized Brain Health Service for Dementia Prevention in People with Subjective Cognitive Decline
This study tests a personalized Brain Health Service to see if tailored risk assessment and a 6‑month lifestyle program can lower dementia risk for people aged 55–85 who have subjective cognitive concerns.
-
Virtual reality-based cognitive and physical rehab for people with mild cognitive impairment or subjective cognitive decline
This study tests whether VR-based cognitive and physical rehabilitation is feasible, usable, and acceptable for people with mild cognitive impairment or subjective cognitive decline.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.